We do what we do for a reason

Posted on January 08, 2014

There was a talk given at a recent conference by a man named Rick Roberts, who has been a victim of both drug shortages and counterfeit drugs. Mr. Roberts grew up in small town in the US. Due to health problems, he had an inhaler from age one. Because of this, he had many trips to the pharmacy growing up and became very interested in the field, eventually deciding he wanted to be a pharmacist. Mr. Roberts went to college in San Francisco, California, and unfortunately contracted...

cGMP now includes Supply Chain Management

Posted on December 11, 2013

Food and Drug Administration Safety and Innovation Act (FDASIA) was signed into law on July 9, 2012 and addresses several areas, including the drug supply chain.

  • The FDA regulates products from more than 150 countries.
  • There are over 130,000 importers into the US, with over 300,000 foreign facilities providing these goods.
  • FDA regulated shipments at more than 300 US portshave quadrupled over ten years.
  • Finished drugs from overseas account for roughly 40% of Pharmaceuticals in the US
  • In 2008, approximatly 80% of Active Pharmaceutical Ingredients (APIs) were from foreign suppliers.

Under FDASIA the FDA will take different approaches. They may request extensive copies of records for review in lieu of actual site inspections. Products will be considered adulterated if they come from a company that has been found to be out of compliance at ANY location, not just the source of that...